State Of Wisconsin Investment Board Kronos Bio, Inc. Transaction History

State Of Wisconsin Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.23 - $2.25 $50,307 - $92,025	-40,900 Reduced 64.01%	23,000 $29,000
Q2 2023 Aug 14, 2023	SELL	$1.24 - $1.92 $48,484 - $75,072	-39,100 Reduced 37.96%	63,900 $109,000
Q1 2023 May 15, 2023	SELL	$1.34 - $2.62 $57,486 - $112,398	-42,900 Reduced 29.4%	103,000 $150,000
Q4 2022 Feb 14, 2023	SELL	$1.44 - $3.44 $32,175 - $76,863	-22,344 Reduced 13.28%	145,900 $236,000
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $147 - $244	44 Added 0.03%	168,244 $564,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $158,496 - $382,016	50,800 Added 43.27%	168,200 $612,000
Q1 2022 May 13, 2022	BUY	$6.26 - $14.42 $420,672 - $969,024	67,200 Added 133.86%	117,400 $849,000
Q3 2021 Nov 12, 2021	BUY	$18.17 - $24.7 $21,694 - $29,491	1,194 Added 2.44%	50,200 $1.05 Million
Q2 2021 Aug 12, 2021	BUY	$20.08 - $29.02 $984,040 - $1.42 Million	49,006 New	49,006 $1.17 Million

20.7M

31.4K

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.